JP2010531846A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010531846A5 JP2010531846A5 JP2010513952A JP2010513952A JP2010531846A5 JP 2010531846 A5 JP2010531846 A5 JP 2010531846A5 JP 2010513952 A JP2010513952 A JP 2010513952A JP 2010513952 A JP2010513952 A JP 2010513952A JP 2010531846 A5 JP2010531846 A5 JP 2010531846A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- binding fragment
- fragment
- antagonist
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE20070468 | 2007-06-28 | ||
| IE2007/0468 | 2007-06-28 | ||
| US3837208P | 2008-03-20 | 2008-03-20 | |
| US61/038,372 | 2008-03-20 | ||
| IE20080209 | 2008-03-20 | ||
| IE2008/0209 | 2008-03-20 | ||
| PCT/EP2008/058339 WO2009000929A2 (en) | 2007-06-28 | 2008-06-27 | Composition and method for treatment of autoimmune disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010531846A JP2010531846A (ja) | 2010-09-30 |
| JP2010531846A5 true JP2010531846A5 (cg-RX-API-DMAC7.html) | 2011-08-04 |
| JP5554703B2 JP5554703B2 (ja) | 2014-07-23 |
Family
ID=39758798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010513952A Active JP5554703B2 (ja) | 2007-06-28 | 2008-06-27 | 自己免疫疾患の治療のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8580255B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2170392A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5554703B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101808662A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008267151B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2691784C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009000929A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2167129B1 (en) * | 2007-07-05 | 2015-06-17 | Opsona Therapeutics Limited | Compounds and methods for the treatment of renal disease |
| US9981018B2 (en) | 2010-06-08 | 2018-05-29 | The Cleveland Clinic Foundation | Compositions and methods for modulating toll-like receptor 2 activation |
| WO2011156451A2 (en) * | 2010-06-08 | 2011-12-15 | The Cleveland Clinic Foundation | Compositions and methods for modulating toll-like receptor 2 activation |
| US9890202B2 (en) * | 2010-07-19 | 2018-02-13 | Yeda Research And Development Co. Ltd. | Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases |
| US9796979B2 (en) | 2011-03-03 | 2017-10-24 | Quark Pharmaceuticals Inc. | Oligonucleotide modulators of the toll-like receptor pathway |
| AU2012223366B2 (en) | 2011-03-03 | 2017-02-23 | Quark Pharmaceuticals, Inc. | Oligonucleotide modulators of the toll-like receptor pathway |
| HK1220699A1 (zh) * | 2013-03-15 | 2017-05-12 | University Of Florida Research Foundation, Inc. | 治疗神经退行性蛋白质病的化合物 |
| WO2016154586A1 (en) | 2015-03-26 | 2016-09-29 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Toll-like receptor 2 ligands and methods of making and using thereof |
| CN107847657A (zh) * | 2015-06-15 | 2018-03-27 | 生命治疗有限公司 | 用于诱导抗炎反应的组合物和方法 |
| ES3023183T3 (en) | 2018-01-02 | 2025-05-30 | Univ Rush Medical Center | Compositions and methods for treating neurological and other disorders |
| WO2020011869A2 (en) | 2018-07-11 | 2020-01-16 | Roche Innovation Center Copenhagen A/S | Antisense oligonucleotides targeting tlr2 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9927332D0 (en) * | 1999-11-18 | 2000-01-12 | Leiv Eiriksson Nyfotek As | Novel antibody and uses thereof |
| US7388080B2 (en) * | 2003-08-20 | 2008-06-17 | University Of Massachusetts | Selective inhibition of toll-like receptor-2 |
| US8623353B1 (en) | 2003-09-23 | 2014-01-07 | Technische Universitat Munchen | TLR2 antagonistic antibody and use thereof |
| JP2007514648A (ja) * | 2003-10-24 | 2007-06-07 | エーザイ株式会社 | Toll−likereceptor2に関連する疾患及び状態を治療するための化合物及び方法 |
| WO2005079419A2 (en) | 2004-02-17 | 2005-09-01 | The Regents Of The University Of California | Methods of treating immunopathological disorders |
| DE602005021694D1 (de) * | 2004-12-10 | 2010-07-15 | Novimmune Sa | Kombinationstherapien gegen multiple toll-like-rezeptoren und ihre verwendung |
| CN101218254A (zh) * | 2005-02-14 | 2008-07-09 | 惠氏公司 | 白介素-17f抗体及其它il-17f信号传递拮抗剂和它们的用途 |
| US20100143336A1 (en) * | 2007-04-26 | 2010-06-10 | Opsona Therapeutics Limited | Toll-like receptor binding epitope and compositions for binding thereto |
-
2008
- 2008-06-27 EP EP08774497A patent/EP2170392A2/en not_active Withdrawn
- 2008-06-27 CA CA2691784A patent/CA2691784C/en active Active
- 2008-06-27 AU AU2008267151A patent/AU2008267151B2/en active Active
- 2008-06-27 US US12/666,442 patent/US8580255B2/en active Active
- 2008-06-27 JP JP2010513952A patent/JP5554703B2/ja active Active
- 2008-06-27 WO PCT/EP2008/058339 patent/WO2009000929A2/en not_active Ceased
- 2008-06-27 CN CN200880104716A patent/CN101808662A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2514495T3 (es) | Anticuerpos humanizados modificados anti-interleucina-18 | |
| HRP20191341T1 (hr) | Protutijela koja vežu ljudski cgrp receptor | |
| Shaw et al. | Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling | |
| JP2020039360A5 (cg-RX-API-DMAC7.html) | ||
| TWI687440B (zh) | St2l拮抗劑及使用方法 | |
| FI3592384T3 (fi) | Vasta-aineita, jotka spesifisesti sitoutuvat ihmisen IL-1R7:ään | |
| US10618957B2 (en) | Antibody molecules which bind CD79 | |
| JP2022031635A5 (cg-RX-API-DMAC7.html) | ||
| HRP20191342T1 (hr) | Anti-phf-tau antitijela i njihove upotrebe | |
| JP2019214582A (ja) | Cd3/cd38 t細胞再標的化ヘテロ二量体免疫グロブリン及びその製造方法 | |
| JP2012516158A5 (cg-RX-API-DMAC7.html) | ||
| JP2012501670A5 (cg-RX-API-DMAC7.html) | ||
| JP2012501669A5 (cg-RX-API-DMAC7.html) | ||
| HRP20171080T1 (hr) | Protutijela s modificiranim affinitetom za fcrn koja potiču uklanjanje antigena | |
| JP2017522043A5 (cg-RX-API-DMAC7.html) | ||
| JP2012531922A5 (ja) | Toll様受容体2へのヒト化抗体またはその抗原結合部位 | |
| EA201001467A1 (ru) | Моноклональное антитело и способ его использования | |
| JP2015501291A5 (cg-RX-API-DMAC7.html) | ||
| JP6009431B2 (ja) | アフィニティー精製の方法 | |
| EA034647B1 (ru) | Молекулы антител, связывающие cd22 | |
| EP3169705A2 (en) | Molecules with specificity for cd79 and cd22 | |
| CA2526546A1 (en) | Methods for producing antibodies | |
| RU2011145428A (ru) | АНТИТЕЛА ПРОТИВ TNF-α И ИХ ПРИМЕНЕНИЯ | |
| HRP20221260T1 (hr) | Humanizirana i kimerna monoklonska protutijela za cd47 | |
| HRP20200918T1 (hr) | Modificirane mutirane fuzijske molekule interferonskog antitijela |